Thermo Fisher Scientific was founded in 1956 and is headquartered in Waltham, US

Report incorrect company information

President and Chief Executive Officer

Report incorrect company information

Thermo Fisher Scientific has an office in Waltham, Pleasanton, Sacramento, Scoresby and in 180 other locations

Waltham, US (HQ)

168 3rd Ave

Report incorrect company information

Thermo Fisher Scientific's revenue was reported to be $20.92 b in FY, 2017

USD | |
---|---|

## Revenue (FY, 2017) | 20.9 b |

## Net income (FY, 2017) | 2.2 b |

## EBIT (FY, 2017) | 3 b |

## Market capitalization (5-Mar-2018) | 81.5 b |

## Cash (6-Mar-2018) | 1.3 b |

Thermo Fisher Scientific's current market capitalization is $81.5 b.

- Source: SEC Filings

Annual

USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
---|---|---|---|---|---|

## Revenue | 13.1 b | 16.9 b | 17 b | 18.3 b | 20.9 b |

| 29% | 0% | 8% | ||

## Cost of goods sold | 7.6 b | 9.4 b | 9.2 b | 9.9 b | |

## Gross profit | 5.5 b | 7.5 b | 7.8 b | 8.4 b |

Quarterly

USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q3, 2016 | Q1, 2016 | Q2, 2016 | Q1, 2017 | Q2, 2017 |
---|---|---|---|---|---|---|---|---|---|---|---|---|

## Revenue | 3.2 b | 3.9 b | 4.3 b | 4.2 b | 3.9 b | 4.3 b | 4.1 b | 4.5 b | 4.3 b | 4.5 b | 4.8 b | 5 b |

## General and administrative expense | 848.5 m | 1.2 b | 1.3 b | 1.2 b | 1.1 b | 1.2 b | 1.1 b | 1.3 b | 1.2 b | 1.2 b | 1.3 b | 1.3 b |

## R&D expense | 95.9 m | 149.7 m | 183.7 m | 175.2 m | 165.8 m | 174.6 m | 171.6 m | 183.3 m | 176.5 m | 182.4 m | 215.4 m | 221.6 m |

## Operating expense total | 2.8 b | 3 b | 4 b | 3.5 b | 3.4 b | 3.7 b | 3.6 b | 3.9 b | 3.8 b | 3.9 b | 4.1 b | 4.2 b |

- Source: SEC Filings

Annual

Quarterly

USD | Q2, 2015 | Q3, 2015 | Q3, 2016 | Q1, 2016 | Q2, 2016 | Q1, 2017 | Q2, 2017 |
---|---|---|---|---|---|---|---|

## Cash | 768.4 m | 503.4 m | 2 b | 826.8 m | 663.1 m | 713.3 m | 611 m |

## Inventories | 2 b | 2 b | 2.4 b | 2.2 b | 2.1 b | 2.3 b | 2.4 b |

## Current Assets | 6.2 b | 6 b | 8.2 b | 6.5 b | 6.3 b | 7.2 b | 7.5 b |

## PP&E | 2.4 b | 2.6 b | 2.5 b | 2.5 b | 2.6 b | 2.6 b |

Annual

Quarterly

USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q3, 2016 | Q1, 2016 | Q2, 2016 | Q1, 2017 | Q2, 2017 |
---|---|---|---|---|---|---|---|---|---|---|---|---|

## Net Income | 931.2 m | 543.1 m | 821.6 m | 1.3 b | 385.1 m | 896.7 m | 1.4 b | 1.4 b | 402.2 m | 918.8 m | 551.4 m | 1.2 b |

## Depreciation and Amortization | 750.6 m | 365.6 m | 800.4 m | 1.3 b | 416.3 m | 836 m | 1.3 b | 1.3 b | 416.1 m | 851.2 m | 464.5 m | 942.7 m |

## Inventories | (129.7 m) | (32.1 m) | (53.8 m) | (109.1 m) | (81.3 m) | (122.1 m) | (175.3 m) | 22.3 m | (56.2 m) | (25.9 m) | (105.1 m) | (146.1 m) |

## Accounts Payable | 49.1 m | (9.8 m) | 3.4 m | (3.3 m) | 34.8 m | 21.7 m | (26.9 m) | 66.1 m | 34.8 m | 39.9 m | 114 m | 49 m |

USD | Y, 2017 |
---|---|

## Revenue/Employee | 380.3 k |

## Financial Leverage | 2.2 x |

Thermo Fisher Scientific's Customers was reported to be 400 k in FY, 2016.

FY, 2016 | |
---|---|

## Customers | 400 k |

Acquired Company | Date | Deal Size |
---|---|---|

Patheon | August 29, 2017 | $7.20 b |

Core Informatics | March 07, 2017 |

Report incorrect company information